仿DC-SIGNSARS-CoV-2

Jonathan Cramer1,2, Xiaohua Jiang1, Butrint Aliu1

  • 1Department of Pharmaceutical Sciences, Group Molecular Pharmacy, Pharmazentrum, University of Basel, Basel, Switzerland.

Archiv der Pharmazie
|December 12, 2023
PubMed
概括

针对树突细胞特异性ICAM-3抓取非整体素 (DC-SIGN) 的新型甘氨酸衍生配体在抑制病毒进入方面表现出高强度. 这些多价DC-SIGN配体为广谱抗病毒疗法提供了一个有前途的战略.